Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Oct. 9, 2026/PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Unicycive Therapeutics, Inc. IF YOU SUFFERED A LOSS ON YOUR UNICYCIVE THERAPEUTICS, INC. INVESTMENTS,...
Covered in this story
Call it yourself
No calls on $UNCY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Unicycive Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.